Feature Reports

The modern market runs on noise. Every day, millions of traders compete to interpret it faster, sharper, and with fewer blind spots. Price moves are dissected in seconds, sentiment shifts ripple through social feeds, and algorithms scrape the web for clues about what comes next. In this environment, the edge no longer comes from data… Continue reading Aether Holdings (Nasdaq: ATHR): Building the Future of Investor Intelligence

Every year, millions of patients face cancer treatments that leave more scars than solutions. Basal cell carcinoma, prostate cancer, and acute urinary retention each carry not only physical burdens but staggering financial and emotional costs. Hospitals are overextended. Insurers are under pressure. Patients endure painful procedures, slow recoveries, and therapies that often fail to improve… Continue reading Medicus Pharma (Nasdaq: MDCX) Bringing Scar-Free, Outpatient Treatment to an $8 Billion Cancer Market

US Edition Member Subscribe Switch edition MEDICUS PHARMA LTD. Add to a listPDF Report Medicus Pharma Ltd. Stocks MDCX CA58471K2020 Pharmaceuticals Real-time Estimate Cboe BZX 03:00:00 2026-09-17 pm EDT 5-day change 1st Jan Change 0.1760 USD +12.68% +8.18% -88.59% Sep. 10 Medicus Pharma Publishes Abridged Final Phase 2 SkinJect Clinical Study Report Results Identifying 200… Continue reading Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress

In the biotech sector, meaningful news often serves as the spark that brings smaller companies into sharper investor focus. Clinical readouts, regulatory decisions, and strategic acquisitions can materially shift the outlook for a business that may have otherwise flown under the radar. These developments not only shape the future of a company’s pipeline but can… Continue reading Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress

Biotech is once again capturing investor attention, with small-cap companies in particular drawing focus for their potential to deliver breakthrough therapies and regulatory milestones. Over the past six months, clinical-stage biotechs reporting meaningful data have moved an average of nearly 12 percent in a single day, showing how quickly the market reacts to progress. With… Continue reading Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data

The crucial role of vaccines in protecting public health couldn’t have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023. At the height of the pandemic, Cominarty, which was jointly… Continue reading Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market           

The crucial role of vaccines in protecting public health couldn’t have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023. At the height of the pandemic, Cominarty, which was jointly… Continue reading Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market

Over the past few months, the once-niche drone market has evolved into a compelling, investable secular story. Regulatory friction is giving way to clarity. On August 5, 2025, the U.S. Department of Transportation, alongside the FAA and TSA, unveiled a Notice of Proposed Rulemaking (NPRM) aimed at normalizing Beyond Visual Line of Sight (BVLOS) drone… Continue reading The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum

As the wellness industry evolves, there is increasing interest in products that address specific consumer needs beyond traditional health solutions. One area with limited innovation has been managing the effects of alcohol consumption. Safety Shot, Inc. (Nasdaq: SHOT) is making strides in this space with its flagship drink. Safety Shot is a patented beverage designed to lower… Continue reading Safety Shot, Inc. (NASDAQ: SHOT): Upside Confirmed by Scientific Research